Small-molecule chromatin-modifying agents: therapeutic applications. - Wikidata - awgldk - TriplyDB

Small-molecule chromatin-modifying agents: therapeutic applications.

Small-molecule chromatin-modifying agents: therapeutic applications.

http://www.wikidata.org/entity/Q37961728

about

Emerging drugs and vaccines for candidemia Properly substituted analogues of BIX-01294 lose inhibition of G9a histone methyltransferase and gain selective anti-DNA methyltransferase 3A activity.CellFateScout - a bioinformatics tool for elucidating small molecule signaling pathways that drive cells in a specific direction Epigenetic drugs: a novel anti-aging strategy?Epigenetic drug discovery for Alzheimer's disease.Targeting Histone Demethylases: A New Avenue for the Fight against Cancer.tert-Butylcarbamate-containing histone deacetylase inhibitors: apoptosis induction, cytodifferentiation, and antiproliferative activities in cancer cells.Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.The histone deacetylase sirtuin 2 is a new player in the regulation of platelet function.Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells Developing novel non-hydroxamate histone deacetylase inhibitors: the chelidamic warhead

P2860

Q26828993-2B524609-3D87-467D-A7FF-A177AC38088A Q28538629-7DC0237E-AD84-4A26-8294-0B5A150A0837 Q35037256-F0092117-5E0D-4F27-84E2-242A23827273 Q36357400-199F7054-393F-4978-9AE7-0CA4A499066B Q38225708-EDC5164C-311C-4F51-B1EA-89DD448C1D3E Q38459037-85DE937C-7DBA-467D-94AC-691224BB9C2F Q39176128-0F887818-C169-4540-BB8B-051A140A1261 Q40045666-BF9E783E-A06A-49D8-B2B8-FCC3CAECC117 Q55059497-F91B84BD-E6FA-4AE8-9DB8-DD8DC013511E Q58855679-F8888CD9-7AD0-4C43-BF02-81EDD4D499EC Q58862227-A39AF081-1F0C-42D5-9341-1E4CB5E7EE73

P2860

Small-molecule chromatin-modifying agents: therapeutic applications.

http://www.wikidata.org/entity/Q37961728

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Small-molecule chromatin-modifying agents: therapeutic applications.

@en

Small-molecule chromatin-modifying agents: therapeutic applications.

@nl

type

label

Small-molecule chromatin-modifying agents: therapeutic applications.

@en

Small-molecule chromatin-modifying agents: therapeutic applications.

@nl

prefLabel

Small-molecule chromatin-modifying agents: therapeutic applications.

@en

Small-molecule chromatin-modifying agents: therapeutic applications.

@nl

P1433

Q37961728-E00B77C4-E069-4E35-B95A-ACDFEC0FC881

P1476

Q37961728-92D675E9-E2D4-4564-9557-469CF237D32E

P2860

Q37961728-030CCC23-3F36-42CB-83D7-D30A0E0F0299

Q37961728-060F1D53-D0CC-4E42-8D2E-82EFE99C8E03

Q37961728-06148894-B09D-424D-A4F7-451968A91BF2

Q37961728-061DFBA9-4BF6-401A-90C0-D143767F9508

Q37961728-0C854112-C96E-4160-83C3-D339CFC85E42

Q37961728-0E41AAAA-4ABF-4306-BC9A-16398FDEF3E7

Q37961728-0EF4FC4F-CF26-4789-8BDC-09AAD016384A

Q37961728-0EFFB33C-7CFE-456B-8CF9-24CD16984C6B

Q37961728-107AF34D-5E3C-4F4B-B94F-8A4C4A40A1CF

Q37961728-10E3A8F5-F9FA-4D0F-B6A8-37F822BCB8AC

P304

Q37961728-A8C86157-8FA2-48EC-9DDF-3F3DB01EA516

P31

Q37961728-6B43495F-0739-46CC-89B0-14193D776430

P356

Q37961728-E98E4060-A35F-4CDB-B911-624B272F3F33

P433

Q37961728-A3805814-1260-42ED-9457-50C3FE63E221

P478

Q37961728-FC68B812-8A0B-4448-8FDC-120DAE466B7B

P50

Q37961728-FFDB8810-0821-41F6-8DA4-99B32BDA1A26

P577

Q37961728-00B66C07-7EE7-41E3-9158-4C4F4C86FB6A

P698

Q37961728-1DE6CBBA-DE89-4970-805E-6D1B669225F7

P356

P1433

P1476

Small-molecule chromatin-modifying agents: therapeutic applications.

@en

P2860

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase

HDAC6 is a microtubule-associated deacetylase

Class II histone deacetylases: versatile regulators

Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity

Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain

SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis

P304

307-324

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/EPI.10.7

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22121876

http://www.w3.org/2001/XMLSchema#string